1
REGN stock showed a trendline breakout in the last session.
2
Buyers are willing to exceed the gains toward $800.
Regeneron Pharmaceuticals (REGN stock) price showed a breakout above the trendline and a round spot of $750 in the last session. Moreover, it surpassed the significant moving averages and showed massive buying with a gap-up opening due to the positive reflection from the Q2 earnings results. The results were above the estimates, total revenues increased by 6.64% to $3.16 Billion (YoY). However, the net income fell by 15.99% to $817.80 Million.
The price action shows that the price has shown a breakout of the falling channel and gave bullish indications. Moreover, the technical parameters suggest a rise toward $800 based on the massive long buildup activity in the last session. Furthermore, the shorts were trapped, and the short-covering rally will exceed if the price is above $765 in the following sessions.
The chart suggests that REGN stoc
We współpracy z: https://www.thecoinrepublic.com/2023/08/04/regn-stock-nasdaqregn-surpasses-hurdle-will-it-catch-800/
